Eng
Assessment of the safety and efficacy of the use of neural crest-derived cells (NC-MSCs) in patients with the effects of spinal cord injury.
Evaluation of safety and efficacy of paravertebral introduction of cultured autologous cells of neural crest-derived (NC-MSCs) from human hair follicles in patients with spine and spinal cord injuries.
The medical product of cultured autologous NC-MSCs obtained from a hair follicle by punch-biopsy.
Up to 100 million cells
Treating patients with spine and spinal cord injuries with NC-MSCs is performed by paravertebral introduction.